© 2022 MJH Life Sciences and AJMC - Managed Care News, Research, and Expert Insights. All rights reserved.
© 2022 MJH Life Sciences™ and Clinical Care Targeted Communications, LLC. All rights reserved.
July 14th 2022, 11:01pm
Additional population-based studies of autoimmune hemolytic anemia and its management are needed to reduce mortality in this patient population.
July 4th 2022, 9:00pm
New data show the types of malignancies, such as leukemias and myeloproliferative disorders, that are most common in children with Langerhans cell histiocytosis (LCH).
July 1st 2022, 11:05pm
The patient was 52 years old and underwent a liver transplant 13 years after his hematopoietic stem cell transplant (HSCT) to treat his sickle cell disease (SCD).
June 28th 2022, 9:11pm
Creating and validating effective risk assessment models could help facilitate appropriate prophylaxis for hemophilia, but more research is needed to confirm the prognostic value of various clinical risk factors and biomarkers.
June 20th 2022, 5:31pm
A new report offers novel insights into a very small patient population.
June 17th 2022, 7:45pm
Surveys of health care professionals, patients, and caregivers explored unmet needs in sickle cell disease (SCD), as well as the significant impact the disease has on everyday life.
June 15th 2022, 6:01pm
Investigators said the benefits appeared relatively early in treatment for many patients and persisted throughout the study period.
June 10th 2022, 2:14pm
A systematic review and meta-analysis found no clear advantage for automated red cell exchange.
June 3rd 2022, 12:05pm
Prior to the pandemic, youth with sickle cell disease were more likely to report depressive symptoms, but the opposite was true during the pandemic.
June 2nd 2022, 2:16pm
A cure for sickle cell disease could more than double the lifetime incomes of patients, the study found.